Cronos Group's Q1 2023 net revenue decreased by $4.9 million compared to Q1 2022, primarily due to lower cannabis flower sales in the Rest of World segment and a decline in the U.S. segment. However, the company is on track to achieve the high end of its projected $10 to $20 million in cash operating expense savings for 2023 and is targeting positive cash flow in 2024.
Net revenue of $20.1 million decreased by $4.9 million from Q1 2022.
Gross profit of $2.4 million decreased by $4.5 million from Q1 2022.
Adjusted EBITDA of $(16.8) million improved by $2.1 million from Q1 2022.
Cash and short-term investments totaled $836 million.
Cronos expects net revenue for full-year 2023 to be between $100 to $110 million and is on track to achieve the high-end of the previously identified $10 to $20 million in operating expense savings for 2023. The Company also expects that cash flow will be positive in 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance